InsiderTrades

Form 4 for HCA HCA Healthcare

Accepted 2022-10-27 00:00:00 ET · period of report 2022-10-25 · accession 0001209191-22-054745 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-10-27 2022-08-10 HCA Sowell Joseph A III SVP, Chief Development Off G - Gift $0.00 -17.1K 0 -100% $0
DMI 2022-10-27 2022-08-04+ HCA Sowell Joseph A III SVP, Chief Development Off G - Gift $0.00 +8,451 33.4K +34% $0
D 2022-10-27 2022-10-25 HCA Sowell Joseph A III SVP, Chief Development Off M - OptEx $47.97 +27.5K 27.5K New +$1.32M
D 2022-10-27 2022-10-25 HCA Sowell Joseph A III SVP, Chief Development Off F - Tax $214.40 -14.6K 12.9K -53% -$3.12M
D 2022-10-27 2022-10-25 HCA Sowell Joseph A III SVP, Chief Development Off M - OptEx $0.00 -27.5K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-08-10 G D 17,051 $0.00 0 D By Trust (Reporting Person and Spouse, Trustees) — —
2 Common Common Stock 2022-08-04 G D 5,000 $0.00 16,320 I By Trust (Reporting Person and Spouse, Trustees) — —
3 Common Common Stock 2022-10-25 M A 27,500 $47.97 27,500 D — —
4 Common Common Stock 2022-10-25 G D 3,600 $0.00 29,771 I — —
5 Common Common Stock 2022-10-25 F D 14,554 $214.40 12,946 D — —
6 Common Common Stock 2022-08-10 G A 17,051 $0.00 33,371 I By Trust (Reporting Person and Spouse, Trustees) — —
7 Derivative Stock Appreciation Right 2022-10-25 M D 27,500 $0.00 0 D $47.97 · — to 2024-02-05 27,500 Common Stock (F1) The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.